Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Airway macrophage impairment is a central feature in the immunopathogenesis of chronic obstructive pulmonary disease, regardless of smoking status.
| Condition |
|---|
|
Pulmonary Disease, Chronic Obstructive Bronchitis, Chronic Occupational Diseases Tobacco Use Disorder |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction |
- Determine if airway macrophages from adult subjects with airflow obstruction demonstrate impaired innate immune cell surface marker expression and phagocytic ability compared to healthy controls. [ Time Frame: One year ] [ Designated as safety issue: No ]
- Determine if airway macrophages from adult subjects with airflow obstruction demonstrate impaired cytokine responsiveness compared to healthy controls. [ Time Frame: One year ] [ Designated as safety issue: No ]
- Determine if airway macrophage cytokine responsiveness is comparable to whole blood cytokine responsiveness. [ Time Frame: One year ] [ Designated as safety issue: No ]
- To determine if airway sputum milieu for potential immunomodulators predict airway macrophage phenotype and function. [ Time Frame: One year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 30 |
| Study Start Date: | August 2008 |
| Estimated Study Completion Date: | June 2009 |
| Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Group One
Healthy non-smoking controls
|
|
Group Two
Smoking adults with chronic bronchitis/chronic obstructive pulmonary disease
|
|
Group Three
Non-smoking adults with chronic bronchitis/chronic obstructive pulmonary disease
|
Detailed Description:
In the United States, a variety of farming operations can generate significant amounts of dust. Chronic organic dust exposure to workers in this industry can result in several respiratory health conditions including chronic bronchitis, chronic obstructive pulmonary disease (COPD), and exacerbations of asthma. Organic dust is a complex mixture containing particulate matter and microbial-associated components from gram positive and gram negative bacteria. Airway macrophages are key innate immune cells that are rapidly activated by exposure to inhaled toxins and organic dust.
The literature indicates that subjects with tobacco-induced chronic bronchitis/COPD have alveolar macrophages that have impaired function. It has been hypothesized that the impaired lung macrophage function may contribute to the increased susceptibility to infections and chronic bacterial colonization that is a central feature in subjects with chronic bronchitis/COPD. It is unknown at this time if impaired macrophage function is secondary to tobacco-induced effects, or is a central pathologic feature of chronic bronchitis/COPD.
We will explore the expression of innate immune cell surface molecule expression involved in antigen presentation, phagocytic ability, and ex vivo cytokine responses in airway macrophages obtained by induced sputum. We will also collect blood to determine if ex vivo stimulation of blood mimics the inflammatory responses observed with airway macrophages. Comparisons to our past findings in vitro studies, which demonstrated that repetitive organic dust exposure impairs monocyte derived macrophage immune cell surface markers and function, could then be made. This information could lead to future investigations centered on therapeutic interventions to prevent or reverse the underlying lung disease experienced by farmers in this industry.
Eligibility| Ages Eligible for Study: | 50 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Three groups Group One : Healthy non-smoking controls Group Two : Smoking adults with chronic bronchitis/COPD Group Three: Non-smoking adults with chronic bronchitis/COPD
Inclusion Criteria:
- Medically stable to participate in induced sputums
- Group One: Smoked less than 100 cigarettes in their lifetime Quit smoking greater than 10 years ago Pre-bronchodilator FEV1/FVC > 70% Pre-bronchodilator FEV1 % predicted > 80%
- Group Two: Greater than a 20-pack year tobacco history Smoked in the last two years Post-bronchodilator FEV1/FVC < 70%
- Group Three:Have less than a 20-pack year tobacco history Quit smoking greater than 20 years ago Post-bronchodilator FEV1/FVC < 70%
Exclusion Criteria:
- Personal history of lung cancer
- Pregnancy
- Personal history of autoimmune disease
- Currently taking oral/parental corticosteroids
- Personal history of upper or lower respiratory tract infection in the prior four weeks
Contacts and Locations| Contact: Jill A Poole, MD | 402-955-3817 | japoole@unmc.edu |
| Contact: Janel R Harting, MD | 402-955-3817 | jharting@unmc.edu |
| United States, Nebraska | |
| University of Nebraska | Recruiting |
| Omaha, Nebraska, United States, 68198 | |
| Contact: Jill A Poole, MD 402-955-3817 japoole@unmc.edu | |
| Contact: Janel R Harting, MD 402-955-3817 jharting@unmc.edu | |
| Principal Investigator: Jill A Poole, MD | |
| Principal Investigator: | Jill A Poole, MD | University of Nebraska |
More Information
No publications provided by University of Nebraska
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Jill A Poole, M.D., University of Nebraska Medical Center |
| ClinicalTrials.gov Identifier: | NCT00871637 History of Changes |
| Other Study ID Numbers: | 222-08-FB |
| Study First Received: | March 26, 2009 |
| Last Updated: | March 26, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Nebraska:
|
Pulmonary disease, chronic obstructive Airway macrophages Sputum milieu Airway inflammation Occupational diseases |
Additional relevant MeSH terms:
|
Bronchitis, Chronic Bronchitis Chronic Disease Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive Occupational Diseases Tobacco Use Disorder |
Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Respiratory Tract Infections Disease Attributes Pathologic Processes Substance-Related Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 19, 2013